Hassan SS, Mukhtar EJHA, Madlum KN. Metabolic pathways inhibitors can affect the therapeutic efficiency of doxorubicin. Int. J. of Health Sci. [Internet]. 2022 May 15 [cited 2026 May 10];6(S2):9099-108. Available from: https://sciencescholar.us/journal/index.php/ijhs/article/view/7375